文献速递关节外科

夏科神经关节病髋关节患者全髋关节置换术后的结局

Outcomes Following Total Hip Arthroplasty in Patients Who Have Charcot Neuroarthropathy of the Hip.
PubMed 文献 · J Arthroplasty · 2023-06-08

基于国家保险数据库,比较895例夏科神经关节病髋(CNH)患者初次全髋关节置换术(THA)与8785例按年龄、性别和合并症1:10匹配的无CNH对照。CNH组90天伤口并发症、假体周围感染、脱位、无菌性松动、假体周围骨折及1年和2年翻修风险更高,但作者指出这些风险低于既往文献报告。

要点

  • CNH患者THA后90天伤口并发症风险更高(P = .014)。
  • CNH患者假体周围感染风险更高(P = .013)。
  • CNH患者脱位、无菌性松动、假体周围骨折及翻修风险均更高。

核心结论

  • CNH患者THA后伤口和植入物相关并发症风险更高,但相对低于既往文献报告。
  • 骨科医生应认识到该人群风险增加,以提供适当的术前咨询和加强围手术期医疗管理。

研究设计与样本

  • 在国家保险数据库中识别接受初次THA且随访至少2年的CNH患者。
  • 按年龄、性别和相关合并症以1:10匹配无CNH对照队列。
  • 895例CNH患者与8785例对照比较,采用多因素logistic回归评估医学结局、急诊就诊、再入院及翻修等手术结局。

主要发现

  • CNH组90天伤口并发症风险更高(P = .014)。
  • CNH组假体周围感染风险更高(P = .013)。
  • CNH组脱位风险更高(P < .001)。
  • CNH组无菌性松动风险更高(1年P = .040,2年P = .002)。
  • CNH组假体周围骨折风险更高(1年P = .003,2年P < .001)。

临床怎么用

  • 骨科医生应认识到CNH患者THA后并发症风险增加,以提供适当的术前咨询和加强围手术期医疗管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Historically, Charcot neuroarthropathy hip (CNH) was deemed a contraindication for total hip arthroplasty (THA). However, as implant design and surgical techniques advance, THA for CNH has been performed and documented in literature. Information regarding the outcomes of THA for CNH is limited. The objective of the study was to assess outcomes following THA in patients who have CNH. METHODS: Patients who have CNH underwent primary THA and had at least 2 years of follow-up were identified in a national insurance database. For comparison, a 1:10 matched control cohort of patients who did not have CNH was created based on age, sex, and relevant comorbidities. Eight hundred and ninety-five CNH patients who underwent primary THA were compared to 8,785 controls. Medical outcomes, emergency department visits, hospital readmissions, and surgical outcomes including revisions between cohorts were evaluated using multivariate logistic regressions. RESULTS: The CNH patients were found to have higher risks of 90-day wound complications (P = .014), periprosthetic joint infection (P = .013) (P = .021), dislocation (P < .001) (P < .001), aseptic loosening (P = .040) (P = .002), periprosthetic fracture (P = .003) (P < .001), and revision (P < .001) (P < .001) at 1-year and 2-year follow-up, respectively. CONCLUSION: While patients who have CNH are at a higher risk of wound and implant-related complications, they are comparatively lower than previously reported in literature. Orthopaedic surgeons should be cognizant of the increased risk in this population to provide appropriate preoperative counseling and enhanced perioperative medical management.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Chi J, Raso J, et al. Outcomes Following Total Hip Arthroplasty in Patients Who Have Charcot Neuroarthropathy of the Hip. J Arthroplasty. 2023. PMID: 37295623. doi:10.1016/j.arth.2023.05.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。